Journal article
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
GS Ngian, W Stevens, D Prior, E Gabbay, J Roddy, A Tran, R Minson, C Hill, K Chow, J Sahhar, S Proudman, M Nikpour
Arthritis Research and Therapy | BioMed Central | Published : 2012
DOI: 10.1186/ar4051
Abstract
Introduction Pulmonary arterial hypertension (PAH) is a major cause of mortality in connective tissue disease (CTD). We sought to quantify survival and determine factors predictive of mortality in a cohort of patients with CTD-associated PAH (CTD-PAH) in the current era of advanced PAH therapy. Methods Patients with right heart catheter proven CTD-PAH were recruited from six specialised PAH treatment centres across Australia and followed prospectively. Using survival methods including Cox proportional hazards regression, we modelled for all-cause mortality. Independent variables included demographic, clinical and hemodynamic data. Results Among 117 patients (104 (94.9%) with systemic scler..
View full abstractRelated Projects (1)
Grants
Funding Acknowledgements
Financial support for this study was provided by The University of Melbourne, Scleroderma Australia, Arthritis Australia, Actelion Australia, Pfizer and GlaxoSmithKline